Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide
The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
Plasmacytoid dendritic cells (pDCs) sense viral and microbial DNA through endosomal Toll-like receptors to produce type 1 interferons. pDCs do not normally respond to self-DNA, but this restriction seems to break down in human autoimmune disease by an as yet poorly understood mechanism. Here we identify the antimicrobial peptide LL37 (also known as CAMP) as the key factor that mediates pDC activation in psoriasis, a common autoimmune disease of the skin. LL37 converts inert self-DNA into a potent trigger of interferon production by binding the DNA to form aggregated and condensed structures that are delivered to and retained within early endocytic compartments in pDCs to trigger Toll-like receptor 9. Thus, our data uncover a fundamental role of an endogenous antimicrobial peptide in breaking innate tolerance to self-DNA and suggest that this pathway may drive autoimmunity in psoriasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the anti-microbial peptide LL37 has been shown to promote trafficking of aggregated DNA structures to the early endosome, promoting TLR9 activation and interferon production (Lande et al., 2007)”
From Cytoplasmic DNA: sources, sensing, and role in aging and disease (2021) · cites this paper as Lande et al., 2007
In the citing paper
“Interestingly, suction blister wounds, where the blister roof is still intact, do not show substantial inflammation,9 whereas excisional wounds, ultraviolet (UV)-induced skin damage, superficial tape stripping or chemical skin irritants, and contact sensitizers cause inflammatory infiltrates,17,23–26”
From The Innate Immune System in Acute and Chronic Wounds (2016) · cites this paper as [23]
Citations
Cites
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952
Antimicrobial peptides of multicellular organisms
Zasloff, M. (2002) · Nature · doi:10.1038/415389a · Cited by 8,457
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., & Reis e Sousa, C. (2004) · Science · doi:10.1126/science.1093616 · Cited by 3,444
CpG Motifs in Bacterial DNA and Their Immune Effects
Krieg, A. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064842 · Cited by 2,573
IRF-7 is the master regulator of type-I interferon-dependent immune responses
Honda, K., Yanai, H., Negishi, H., Asagiri, M., Sato, M., Mizutani, T., Shimada, N., Ohba, Y., Takaoka, A., Yoshida, N., et al. (2005) · Nature · doi:10.1038/nature03464 · Cited by 2,245
Kadowaki, N., Ho, S., Antonenko, S., de Waal Malefyt, R., Kastelein, R. A., Bazan, F., & Liu, Y.-J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.863 · Cited by 1,964
Self-citationEndogenous Antimicrobial Peptides and Skin Infections in Atopic Dermatitis
Ong, P. Y., Ohtake, T., Brandt, C., Strickland, I., Boguniewicz, M., Ganz, T., Gallo, R. L., & Leung, D. Y. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021481 · Cited by 1,960
Pathogenesis and therapy of psoriasis
Lowes, M. A., Bowcock, A. M., & Krueger, J. G. (2007) · Nature · doi:10.1038/nature05663 · Cited by 1,778
Plasmacytoid dendritic cells in immunity
Colonna, M., Trinchieri, G., & Liu, Y.-J. (2004) · Nature Immunology · doi:10.1038/ni1141 · Cited by 1,678
Self-citation
Cited by
Items 301–400 of 1,000
Plasmacytoid dendritic cells: one-trick ponies or workhorses of the immune system?
Reizis, B., Colonna, M., Trinchieri, G., Barrat, F., & Gilliet, M. (2011) · Nature Reviews Immunology · doi:10.1038/nri3027 · Cited by 140
Self-citationThe role of the multifunctional peptide LL-37 in host defense
Kai-Larsen, Y. (2008) · Frontiers in Bioscience · doi:10.2741/2964 · Cited by 141
“The complex of LL-37 and self-DNA is sensed by plasmacytoid DCs as a danger signal (67).”
BackgroundKoebner’s phenomenon in vitiligo: European position paper
van Geel, N., Speeckaert, R., Taïeb, A., Picardo, M., Böhm, M., Gawkrodger, D. J., Schallreuter, K. U., Bennett, D. C., van der Veen, W., Whitton, M. E., et al. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00838.x · Cited by 147
“, LL37; also known as CAMP or cathelicidin) produced in damaged skin (Conrad et al., 2009; Lande et al., 2007).”
BackgroundLee, E. Y., Lee, M. W., Fulan, B. M., Ferguson, A. L., & Wong, G. C. L. (2017) · Interface Focus · doi:10.1098/rsfs.2016.0153 · Cited by 157
Genetic Epidemiology of Psoriasis
Gupta, R., Debbaneh, M. G., & Liao, W. (2014) · Current Dermatology Reports · doi:10.1007/s13671-013-0066-6 · Cited by 137
Nijnik, A., & Hancock, R. E. W. (2009) · Emerging Health Threats Journal · doi:10.3134/ehtj.09.001 · Cited by 204
Hanagata, N. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s114477 · Cited by 148
“32 This type of TLR9-mediated IFN-α induction, independent of CpG, was also observed in complexes of double-stranded natural phosphodiester DNA and human β -defensin-3 or penetratin, but it was not observed in complexes with Tat-derived peptides.”
BackgroundEpigenetic control of IL-23 expression in keratinocytes is important for chronic skin inflammation
Li, H., Yao, Q., Mariscal, A. G., Wu, X., Hülse, J., Pedersen, E., Helin, K., Waisman, A., Vinkel, C., Thomsen, S. F., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03704-z · Cited by 137
Unique features of human cathelicidin LL ‐37
Bandurska, K., Berdowska, A., Barczyńska, R., & Krupa, P. (2015) · BioFactors · doi:10.1002/biof.1225 · Cited by 147
“They induce the production and release of type I interferons and the maturation of dendritic cells [133,134].”
BackgroundYan, H., Zhou, H., Akk, A. M., Hu, Y., Springer, L. E., Ennis, T. L., & Pham, C. T. N. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.307786 · Cited by 150
“We first examined human AAA tissues for the presence of the NET component LL-37, the human orthologue of CRAMP.28 We detected abundant expression of LL-37; some of which localized to the vicinity of CD303+ (a marker for human pDCs) cells (Figure 6A) and could be seen taken up inside CD303+ cells (Figure IV in the onli…”
BackgroundInfluentialDendritic cells: The driver of psoriasis
Wang, A., & Bai, Y. (2020) · The Journal of Dermatology · doi:10.1111/1346-8138.15184 · Cited by 136
Emerging Roles of Vitamin D-Induced Antimicrobial Peptides in Antiviral Innate Immunity
White, J. H. (2022) · Nutrients · doi:10.3390/nu14020284 · Cited by 161
Cathelicidins prime platelets to mediate arterial thrombosis and tissue inflammation
Pircher, J., Czermak, T., Ehrlich, A., Eberle, C., Gaitzsch, E., Margraf, A., Grommes, J., Saha, P., Titova, A., Ishikawa-Ankerhold, H. C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03925-2 · Cited by 155
Significance of LL‐37 on Immunomodulation and Disease Outcome
Yang, B., Good, D. M., Mosaiab, T., Liu, W., Ni, G., Kaur, J., Liu, X., Jessop, C., Yang, L., Fadhil, R., et al. (2020) · BioMed Research International · doi:10.1155/2020/8349712 · Cited by 169
“Thus, LL-37 converts inert self-nucleic acid into a potent trigger of interferon production by pDCs in psoriatic skin [76].”
BackgroundDongye, Z., Li, J., & Wu, Y. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01876-6 · Cited by 149
“In addition to CpG-ODN, TLR9 can also be activated by endogenous ligands, including heat shock proteins [39], antimicrobial peptide LL37 [40] and high mobility group protein B1 (HMGB1) [41] and so on.”
BackgroundNeutrophil Extracellular Traps: Mechanisms of formation and role in health and disease
Vorobjeva, N. V., & Pinegin, B. V. (2014) · Biochemistry (Moscow) · doi:10.1134/s0006297914120025 · Cited by 159
“Type I IFNs deficiency leads to enhanced susceptibility to infectious diseases and some types of cancer, while its excess results in the development of autoimmune disorder [16, 17].”
BackgroundInfluentialFarina, G. A., York, M. R., Di Marzio, M., Collins, C. A., Meller, S., Homey, B., Rifkin, I. R., Marshak-Rothstein, A., Radstake, T. R. D. J., & Lafyatis, R. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.200 · Cited by 133
“In SLE, activation of TLR7/8 and TLR9 on dendritic cells through nucleic acidcontaining immune-complexes stimulates type I IFNs.”
BackgroundInfluentialSelf-citationIL-29 Is Produced by T H 17 Cells and Mediates the Cutaneous Antiviral Competence in Psoriasis
Wolk, K., Witte, K., Witte, E., Raftery, M., Kokolakis, G., Philipp, S., Schönrich, G., Warszawska, K., Kirsch, S., Prösch, S., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006245 · Cited by 131
Putting together the psoriasis puzzle: an update on developing targeted therapies
Johnson-Huang, L. M., Lowes, M. A., & Krueger, J. G. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.009092 · Cited by 148
“LL-37 forms complexes with self-DNA (released from dying cells) and, through TLR9 engagement, induces IFN production by pDCs and subsequent activation of myeloid DCs (Lande et al., 2007).”
BackgroundVähävihu, K., Ala-Houhala, M. J., Perić, M., Karisola, P., Kautiainen, H., Hasan, T., Snellman, E., Alenius, H. T., Schauber, J., & Reunala, T. L. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.09767.x · Cited by 130
Choreographing Immunity in the Skin Epithelial Barrier
Kobayashi, T., Naik, S., & Nagao, K. (2019) · Immunity · doi:10.1016/j.immuni.2019.02.023 · Cited by 129
Vitamin D Regulation of Immune Function
Bikle, D. D. (2011) · Vitamins and hormones · doi:10.1016/b978-0-12-386960-9.00001-0 · Cited by 167
Keratin 17: A Critical Player in the Pathogenesis of Psoriasis
Jin, L., & Wang, G. (2013) · Medicinal Research Reviews · doi:10.1002/med.21291 · Cited by 129
Sonawane, S. S., Khanolkar, V., Namavari, A., Chaudhary, S., Gandhi, S., Tibrewal, S., Jassim, S. H., Shaheen, B., Hallak, J., Horner, J. H., et al. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-10430 · Cited by 130
“Cathelicidin binds eDNA and enhances its intracellular entry.(43) Cathelicidin localized within neutrophils and NETs on the ocular surface of patients with severe DED, particularly within the mucoid films.”
BackgroundDefensins: antifungal lessons from eukaryotes
Silva, P. M., Gonçalves, S., & Santos, N. C. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00097 · Cited by 125
“Surprisingly, some defensins are also able to attenuate proinflammatory responses whenever these can be harmful to the organism (Lande et al., 2007; Yamasaki et al., 2007).”
BackgroundRecent advances in understanding psoriasis
Eberle, F. C., Brück, J., Holstein, J., Hirahara, K., & Ghoreschi, K. (2016) · F1000Research · doi:10.12688/f1000research.7927.1 · Cited by 126
The human cathelicidin hCAP18/LL-37: A multifunctional peptide involved in mycobacterial infections
Méndez‐Samperio, P. (2010) · Peptides · doi:10.1016/j.peptides.2010.06.016 · Cited by 143
Bangert, C., Brunner, P. M., & Stingl, G. (2011) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2011.01.006 · Cited by 173
Tversky, J. R., Le, T. V., Bieneman, A. P., Chichester, K. L., Hamilton, R. G., & Schroeder, J. T. (2008) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2008.02954.x · Cited by 125
“Our data are consistent with the mounting evidence that plasmacytoid dendritic cells lie at an important immune axis orchestrating IFN-α associated Th1-like responses via innate immune receptors (TLR9) as well as FcεRI adaptive immune receptor operation and expression on these cells [14,15].”
ResultMcFarlane, A. J., McSorley, H. J., Davidson, D. J., Fitch, P. M., Errington, C., Mackenzie, K. J., Gollwitzer, E. S., Johnston, C. J. C., MacDonald, A. S., Edwards, M. R., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.01.016 · Cited by 125
Human mononuclear phagocyte system reunited
Haniffa, M. A., Bigley, V., & Collin, M. P. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.05.004 · Cited by 148
“self nucleic acids recognition [168–170].”
Yan, J., Wang, K., Dang, W., Chen, R., Xie, J., Zhang, B., Song, J., & Wang, R. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01619-12 · Cited by 130
“Experiments were performed with a multimode nanoscope atomic force microscope (5400; Agilent) operating in contact mode (29, 30).”
MethodAdaptive immunity after cell death
Zelenay, S., & Sousa, C. R. E. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.03.005 · Cited by 138
Mitochondrial DNA-LL-37 Complex Promotes Atherosclerosis by Escaping from Autophagic Recognition
Zhang, Z., Meng, P., Han, Y., Shen, C., Li, B., Hakim, M. A., Zhang, X., Lu, Q., Rong, M., & Lai, R. (2015) · Immunity · doi:10.1016/j.immuni.2015.10.018 · Cited by 132
Recent advances on the crosstalk between neutrophils and B or T lymphocytes
Costa, S., Bevilacqua, D., Cassatella, M. A., & Scapini, P. (2019) · Immunology · doi:10.1111/imm.13005 · Cited by 123
Immunomodulatory Role of the Antimicrobial LL-37 Peptide in Autoimmune Diseases and Viral Infections
Pahar, B., Madonna, S., Das, A., Albanesi, C., & Girolomoni, G. (2020) · Vaccines · doi:10.3390/vaccines8030517 · Cited by 139
“demonstrated that LL-37 is the principal trigger of the pathogenic innate immune responses in psoriatic skin, providing the first link between an antimicrobial defense system and the pathogenesis of psoriasis [19].”
BackgroundInfluentialThe miR-126-VEGFR2 axis controls the innate response to pathogen-associated nucleic acids
Agudo, J., Ruzo, A., Tung, N., Salmon, H., Leboeuf, M., Hashimoto, D., Becker, C., Garrett-Sinha, L.-A., Baccarini, A., Merad, M., et al. (2014) · Nature Immunology · doi:10.1038/ni.2767 · Cited by 122
Fuentes‐Duculan, J., Bonifacio, K. M., Hawkes, J. E., Kunjravia, N., Cueto, I., Li, X., Gonzalez, J., Garcet, S., & Krueger, J. G. (2017) · Experimental Dermatology · doi:10.1111/exd.13378 · Cited by 122
Dendritic cell recruitment and activation in autoimmunity
Sozzani, S., Prete, A. D., & Bosisio, D. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.07.012 · Cited by 126
Jylhävä, J., Nevalainen, T., Marttila, S., Jylhä, M., Hervonen, A., & Hurme, M. (2013) · Aging Cell · doi:10.1111/acel.12058 · Cited by 122
“, 2008), cathelicidin antimicrobial peptide (CAMP) (Lande et al., 2007), and the antichromatin antibodies (Leadbetter et al.”
BackgroundProgress in Understanding the Immunopathogenesis of Psoriasis
Mak, R. K. H., Hundhausen, C., & Nestle, F. O. (2009) · Actas Dermo-Sifiliográficas · doi:10.1016/s0001-7310(09)73372-1 · Cited by 122
Self-citationKanada, K. N., Nakatsuji, T., & Gallo, R. L. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.14 · Cited by 125
“a wide variety of inflammatory skin diseases including psoriasis (Lande et al., 2007) and atopic dermatitis (Ong et al.”
BackgroundThe vitamin D pathway: a new target for control of the skin’s immune response?
Schauber, J., & Gallo, R. L. (2008) · Experimental Dermatology · doi:10.1111/j.1600-0625.2008.00768.x · Cited by 121
Psoriasis and Antimicrobial Peptides
Takahashi, T., & Yamasaki, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186791 · Cited by 119
“showed that LL-37 enhances the recognition of self-DNA through TLR9 in pDCs and enhances inflammation [84].”
BackgroundSuárez, L. J., Garzon, H. S., Arboleda, S., & Rodríguez, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.591255 · Cited by 149
Research gaps in psoriasis: Opportunities for future studies
Ryan, C., Korman, N. J., Gelfand, J. M., Lim, H. W., Elmets, C. A., Feldman, S. R., Gottlieb, A. B., Koo, J. Y. M., Lebwohl, M., Leonardi, C. L., et al. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.08.042 · Cited by 127
Toll-like receptors in skin infections and inflammatory diseases
Lai, Y., & Gallo, R. (2008) · Infectious Disorders - Drug Targets · doi:10.2174/1871526510808030144 · Cited by 119
Extracellular traps and macrophages: new roles for the versatile phagocyte
Boe, D. M., Curtis, B. J., Chen, M. M., Ippolito, J. A., & Kovacs, E. J. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.4ri1014-521r · Cited by 139
Highlighting Interleukin-36 Signalling in Plaque Psoriasis and Pustular Psoriasis
Furue, K., Yamamura, K., Tsuji, G., Mitoma, C., Uchi, H., Nakahara, T., KIDO-NAKAHARA, M., Kadono, T., & Furue, M. (2017) · Acta Dermato Venereologica · doi:10.2340/00015555-2808 · Cited by 126
“An initial trigger of psoriasis is believed to be the activation of plasmacytoid DCs being stimulated by complexes of host DNA and LL-37, which are produced by keratinocytes after minor injuries (37, 38, 61, 62) (Fig.”
BackgroundYasuda, K., Richez, C., Uccellini, M. B., Richards, R. J., Bonegio, R. G., Akira, S., Monestier, M., Corley, R. B., Viglianti, G. A., Marshak-Rothstein, A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900399 · Cited by 118
Interplay between keratinocytes and immune cells—Recent insights into psoriasis pathogenesis
Tonel, G., & Conrad, C. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.10.022 · Cited by 140
Farrugia, M., & Baron, B. (2017) · International Journal of Inflammation · doi:10.1155/2017/8391230 · Cited by 134
“It also efficiently blocked antiribonucleoproteins (RNPs) but not anti-DNA-induced IFN𝛼, indicating the role of TLR7 in this process.”
BackgroundInfluentialPlasmodium falciparum Histones Induce Endothelial Proinflammatory Response and Barrier Dysfunction
Gillrie, M. R., Lee, K., Gowda, D. C., Davis, S. P., Monestier, M., Cui, L., Hien, T. T., Day, N., & Ho, M. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.11.037 · Cited by 117
“Most recently, the TLR9dependent proinflammatory effect of plasmodial components on human plasmacytoid dendritic cells was found to be induced by nucleosomes(12) in which the histones are believed to provide a positive charge that facilitates internalization of parasite DNA, analogous to the role of the antimicrobial…”
BackgroundThe Human Cathelicidin LL-37 Preferentially Promotes Apoptosis of Infected Airway Epithelium
Barlow, P. G., Beaumont, P. E., Cosseau, C., Mackellar, A., Wilkinson, T. S., Hancock, R. E. W., Haslett, C., Govan, J. R. W., Simpson, A. J., & Davidson, D. J. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0250oc · Cited by 115
“lung disease are correlated with increased lung damage (34), and elevated hCAP-18/LL-37 concentrations are associated with bronchiolitis obliterans syndrome (44) and the pathogenesis of psoriasis (45).”
BackgroundTLR9 traffics through the Golgi complex to localize to endolysosomes and respond to CpG DNA
Chockalingam, A., Brooks, J. C., Cameron, J. L., Blum, L. K., & Leifer, C. A. (2008) · Immunology and Cell Biology · doi:10.1038/icb.2008.101 · Cited by 135
LL37 and Cationic Peptides Enhance TLR3 Signaling by Viral Double-stranded RNAs
Lai, Y. Y., Adhikarakunnathu, S., Bhardwaj, K., Ranjith-Kumar, C. T., Wen, Y., Jordan, J. L., Wu, L. H., Dragnea, B. G., Mateo, L. S., & Kao, C. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026632 · Cited by 125
“prevent activation of TLR4 [27], to single-stranded (ss) DNA to enhance signaling by TLR9 [25,27], and to ssRNA to enhance”
BackgroundInfluentialWakkee, M., de Vries, E., van den Haak, P., & Nijsten, T. E. C. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.08.036 · Cited by 123
Nucleic acids and endosomal pattern recognition: how to tell friend from foe?
Brencicova, E., & Diebold, S. S. (2013) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2013.00037 · Cited by 114
“…fail and allow for complex formation of cellular RNA and DNA with antibodies or the antimicrobial peptide LL37, PDC become a driving force for autoimmune induction as observed in SLE and psoriasis, respectively (Lovgren et al., 2004; Barrat et al., 2005; Lande et al., 2007; Ganguly et al., 2009).”
BackgroundMa, S., Wan, X., Deng, Z., Shi, L., Hao, C., Zhou, Z., Zhou, C., Fang, Y., Liu, J., Yang, J., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20161149 · Cited by 115
“…nucleic acids, pDCs can recognize self-DNAs/RNAs released by necrotic cells, and thus have been implicated in the pathogenesis of autoimmune diseases including systemic lupus erythematosus and psoriasis (Lande et al., 2007; Ganguly et al., 2009, 2013; Rowland et al., 2014; Sisirak et al., 2014).”
BackgroundRNA Mediated toll-like receptor stimulation in health and disease
Dalpke, A. H., & Helm, M. (2012) · RNA Biology · doi:10.4161/rna.20206 · Cited by 113
Tang, S., Zhang, Y., Yin, S.-W., Gao, X.-J., Shi, W.-W., Wang, Y., Huang, X., Wang, L., Zou, L.-Y., Zhao, J.-H., et al. (2015) · Clinical & Experimental Immunology · doi:10.1111/cei.12589 · Cited by 116
Self-citationSala, M., Elaïssari, A., & Fessi, H. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.07.003 · Cited by 127
Hyperglycaemia inhibits REG3A expression to exacerbate TLR3-mediated skin inflammation in diabetes
Wu, Y., Quan, Y., Liu, Y., Liu, K., Li, H., Jiang, Z., Zhang, T., Lei, H., Radek, K. A., Li, D., et al. (2016) · Nature Communications · doi:10.1038/ncomms13393 · Cited by 122
Self-citationThe role of plasmacytoid dendritic cells (pDCs) in immunity during viral infections and beyond
Ngo, C., Garrec, C., Tomasello, E., & Dalod, M. (2024) · Cellular and Molecular Immunology · doi:10.1038/s41423-024-01167-5 · Cited by 127
“4), including psoriasis [223, 249] and rosacea [250].”
BackgroundZhang, X., Oglęcka, K., Sandgren, S., Belting, M., Esbjörner, E. K., Nordén, B., & Gräslund, A. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2009.12.011 · Cited by 123
“Recent studies also show that LL-37 forms large aggregated complexes with released “self-DNA” and delivers DNA into dendritic cells, thereby triggering an autoimmune response linked to psoriasis [8].”
BackgroundTewary, P., de la Rosa, G., Sharma, N., Rodríguez, L. G., Tarasov, S. G., Howard, O. M. Z., Shirota, H., Steinhagen, F., Klinman, D. M., Yang, D., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201648 · Cited by 117
“Because injured epithelium is an excellent source of host nucleic acids, as well as HBD2 and 3, we hypothesized that both HBD2 and 3 may complex to DNA released by damaged tissues or cells and may promote IFN-a production by self DNA, similarly to LL37.”
BackgroundMethodInfluentialZhou, J., Wu, R., High, A. A., Slaughter, C. A., Finkelstein, D., Rehg, J. E., Redecke, V., & Häcker, H. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106232108 · Cited by 124
“Next, these complexes trigger the activity of specific Toll-like receptors, such as TLR9 and TLR7, thereby providing a possible link between tissue injury and perpetuation of inflammation (2, 3).”
BackgroundExtracellular DNA traps in allergic, infectious, and autoimmune diseases
Simon, D., Simon, H. ‐., & Yousefi, S. (2013) · Allergy · doi:10.1111/all.12111 · Cited by 112
“In agreement with previous observations that LL-37 may convert self-DNA into an activator of pDC (44), an increased local IFN-alpha production in kidney biopsy specimens from patients with active SLE has been observed (8).”
BackgroundMethodInfluentialGotoh, K., Tanaka, Y., Nishikimi, A., Nakamura, R., Yamada, H., Maeda, N., Ishikawa, T., Hoshino, K., Uruno, T., Cao, Q., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091776 · Cited by 112
“Elucidation of this regulatory mechanism would be clinically important because type I IFNs produced by pDCs have been implicated in the pathogenesis of autoimmune diseases such as psoriasis and systemic lupus erythematosus (Blanco et al., 2001; Nestle et al., 2005; Lande et al., 2007).”
BackgroundBiomarkers of an Autoimmune Skin Disease—Psoriasis
Jiang, S., Hinchliffe, T. E., & Wu, T. (2015) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2015.04.002 · Cited by 120
“psoriatic lesions, with reduced levels of IL-1, IL-4, IL-5, and IL-10, together with increased levels of TNF-a, IFN-a, IL-2, IL-6, IL-8, IL-12, IL-23, IL-23R, and LIF-1 [8].”
BackgroundToll-like receptor co-receptors as master regulators of the immune response
Gioia, M. D., & Zanoni, I. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.05.008 · Cited by 127
Modulation of neutrophil NETosis: interplay between infectious agents and underlying host physiology
Hahn, S., Giaglis, S., Chowdhury, C. S., Hösli, I., & Hasler, P. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0380-x · Cited by 129
“This facet may be due to an unexpected interaction between LL-37 and extracellular host DNA derived from dying cells [47, 48].”
BackgroundAntimicrobial Peptides: Multifunctional Drugs for Different Applications
Brandenburg, L., Merres, J., Albrecht, L.-J., Varoga, D. J., & Pufe, T. (2012) · Polymers · doi:10.3390/polym4010539 · Cited by 128
“On the one side, LL-37 is able to bind self-DNA and RNA which activates plasmacytoid dendritic cells (pDCs) in the skin disease psoriasis [87,88].”
BackgroundAdipose Recruitment and Activation of Plasmacytoid Dendritic Cells Fuel Metaflammation
Ghosh, A. R., Bhattacharya, R., Bhattacharya, S., Nargis, T., Rahaman, O., Duttagupta, P., Raychaudhuri, D., Liu, C. S. C., Roy, S., Ghosh, P., et al. (2016) · Diabetes · doi:10.2337/db16-0331 · Cited by 111
“pDCs are the major producers of type I IFNs in the body (21), and the role of pDC-derived type I IFNs in initiating autoreactive inflammation in several autoimmune disease is well established (18,19,22,23).”
BackgroundPathogenesis, multi-omics research, and clinical treatment of psoriasis
Yu, J., Zhao, Q., Wang, X., Zhou, H., Hu, J. Y., Gu, L., Hu, Y., Zeng, F., Zhao, F., Yue, C., et al. (2022) · Journal of Autoimmunity · doi:10.1016/j.jaut.2022.102916 · Cited by 124
Nucleic acid‐sensing TLR s and autoimmunity: novel insights from structural and cell biology
Pelka, K., Shibata, T., Miyake, K., & Latz, E. (2016) · Immunological Reviews · doi:10.1111/imr.12375 · Cited by 110
“This can, for example, be the case if the degradation of host nucleic acids is impaired (5, 33–39), or if extracellular host nucleic acids are stabilized by nucleic acid-binding proteins (5, 40) (Fig.”
BackgroundCrosstalk: keratinocytes and immune cells in psoriasis
Kamata, M., & Tada, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1286344 · Cited by 110
Damage-associated molecular patterns (DAMPs) in diseases: implications for therapy
Lin, H., Xiong, W. G., Fu, L., Yi, J., & Yang, J. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00305-3 · Cited by 152
Mouchess, M. L., Arpaia, N., Souza, G., Barbalat, R., Ewald, S. E., Lau, L., & Barton, G. M. (2011) · Immunity · doi:10.1016/j.immuni.2011.10.009 · Cited by 109
“Although this strategy enables detection of viral nucleic acid within the degradative environment of intracellular compartments, the cost of this strategy is the potential recognition of self DNA and RNA, which has been implicated in autoimmune diseases such as systemic lupus erythematosus and psoriasis (Lande et al.,…”
Zhang, S., Lu, X., Shu, X., Tian, X., Yang, H., Yang, W., Zhang, Y., & Wang, G. (2014) · Internal Medicine · doi:10.2169/internalmedicine.53.2570 · Cited by 111
“If NETs cannot be degraded completely by DNase I, NETs can form complexes with other proteins and may persist for abnormally long periods, resulting in prolonged antigenic stimulation (10) and deposition on the glomerular basement membrane, thus inducing nephritis (3, 9).”
BackgroundNeutrophil extracellular traps induced by cigarette smoke activate plasmacytoid dendritic cells
Qiu, S., Zhang, H., Tang, Q., Bai, J., He, Z., Zhang, J., Li, M., Deng, J., Liu, G., & Zhong, X. (2017) · Thorax · doi:10.1136/thoraxjnl-2016-209887 · Cited by 113
Sisirak, V., Vey, N., Goutagny, N., Renaudineau, S., Malfroy, M., Thys, S., Treilleux, I., Labidi‐Galy, S. I., Bachelot, T., Dezutter‐Dambuyant, C., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28072 · Cited by 128
“Indeed, pDCs that are chronically activated by (LL37/selfnucleic acids) complexes produced excessive levels of IFN-a that participated to the development/maintenance of noninfectious autoimmune/inflammatory pathologies.(22,23) In contrast, in BT we observed that TApDCs are strongly inhibited for their IFN-a production…”
BackgroundCytokine-Producing Dendritic Cells in the Pathogenesis of Inflammatory Skin Diseases
Johnson-Huang, L. M., McNutt, N. S., Krueger, J. G., & Lowes, M. A. (2009) · Journal of Clinical Immunology · doi:10.1007/s10875-009-9278-8 · Cited by 116
“[46] demonstrated that self-DNA forms aggregates with LL37 (cathelicidin), an antimicrobial peptide that normally acts as a natural “antibiotic” to prevent microbial infection.”
Human Cathelicidin Peptide LL-37 Modulates the Effects of IFN-γ on APCs
Nijnik, A., Pistolic, J., Wyatt, A. W., Tam, S., & Hancock, R. E. W. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901491 · Cited by 125
“LL-37 promotes the responses of bone marrow-derived dendritic cells to peptidoglycan and lipopeptides (13), and also the responses of blood mononuclear cells and plasmacytoid dendritic cells to CpG oligonucleotides (6, 15).”
BackgroundFuruhashi, T., Saito, C., Torii, K., Nishida, E., Yamazaki, S., & Morita, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054895 · Cited by 109
“In particular, the antimicrobial peptide LL37 forms aggregated condensed structures with DNA that are delivered to and retained within early endocytic compartments in pDCs [24].”
BackgroundThe skin surface as antimicrobial barrier: present concepts and future outlooks
Harder, J., Schröder, J., & Gläser, R. (2013) · Experimental Dermatology · doi:10.1111/exd.12046 · Cited by 107
Self-citationModulation of toll-like receptor signaling by antimicrobial peptides
Lee, E. Y., Lee, M. W., & Wong, G. C. L. (2018) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2018.02.002 · Cited by 123
“Inflammatory skin march” in atopic dermatitis and psoriasis
Furue, M., & Kadono, T. (2017) · Inflammation Research · doi:10.1007/s00011-017-1065-z · Cited by 123
“& Masutaka Furue furue@dermatol.med.kyushu-u.ac.jp 1 Department of Dermatology, Kyushu University, Maidashi 3-1-1, Higashiku, Fukuoka 812-8582, Japan 2 Department of Dermatology, St. Marianna University School of Medicine, Kawasaki, Japan IFN-b and TNF-a, which result in further production of TNF-a, IL-12 and IL-23 by…”
BackgroundInfluentialAnti-LL37 Antibodies Are Present in Psoriatic Arthritis (PsA) Patients: New Biomarkers in PsA
Frasca, L., Palazzo, R., Chimenti, M. S., Alivernini, S., Tolusso, B., Bui, L., Botti, E., Giunta, A., Bianchi, L., Petricca, L., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01936 · Cited by 124
“Results of this study suggest novel factors, some of which are also implicated in psoriasis pathogenesis (13, 15, 36), included the antimicrobial peptide LL37, that seem at work in the pathogenesis of PsA and are potential biomarkers of inflammation/disease status.”
BackgroundSelf-citationSignaling Through Nucleic Acid Sensors and Their Roles in Inflammatory Diseases
Okude, H., Ori, D., & Kawai, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.625833 · Cited by 104
Role for toll-like receptors in autoimmune disease: The example of systemic lupus erythematosus
Richez, C., Blanco, P., Rifkin, I. R., Moreau, J., & Schaeverbeke, T. (2010) · Joint Bone Spine · doi:10.1016/j.jbspin.2010.09.005 · Cited by 116
Psoriasis and Systemic Inflammatory Disorders
Tashiro, T., & Sawada, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084457 · Cited by 104
“This complex is recognized by antigen-presenting cells, such as plasmacytoid dendritic cells, and activates antigen-specific T cell expansion in the skin and lymph nodes [15].”
BackgroundAn Eight-Gene Blood Expression Profile Predicts the Response to Infliximab in Rheumatoid Arthritis
Julià, A., Erra, A., Palacio, C., Tomás, C., Sans, X., Barceló, P., & Marsal, S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007556 · Cited by 111
“The remaining predictor genes have all been linked to the immune response or even to autoimmunity [35,36,37,38,39] but, to date, this is the first evidence of their association to anti-TNF alpha treatment response.”
BackgroundSystemic Lupus Erythematosus – A Disease with A Dysregulated Type I Interferon System
Hagberg, N., & Rönnblom, L. (2015) · Scandinavian Journal of Immunology · doi:10.1111/sji.12330 · Cited by 111
The Relapse of Psoriasis: Mechanisms and Mysteries
Tian, D., & Lai, Y. (2022) · JID Innovations · doi:10.1016/j.xjidi.2022.100116 · Cited by 118
“…AMP‒nucleic acid complexes, which activate toll-like receptor (TLR) 7 or 8 to induce the production of type I IFNs (IFN-a and IFN-b) in plasmacytoid dendritic cells (pDCs) or increase the amounts of IL-6 and TNF-a by myeloid dendritic cells (mDCs) (Ganguly et al., 2009; Lande et al., 2007).”
BackgroundMookherjee, N., Hamill, P., Gardy, J. L., Blimkie, D., Falsafi, R., Chikatamarla, A., Arenillas, D. J., Doria, S., Kollmann, T. R., & Hancock, R. E. W. (2009) · Molecular BioSystems · doi:10.1039/b813787k · Cited by 120
Chuang, C.-M., Monie, A., Wu, A. A., Mao, C.-P., & Hung, C. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.124 · Cited by 113
“OVARIAN TUMOR CONTROL WITH CpG AND LL-37 dendritic cells (Lande et al. , 2007).”
Jacquemin, C., Rambert, J., Guillet, S., Thiolat, D., Boukhedouni, N., Doutre, M. ‐., Darrigade, A. ‐., Ezzedine, K., Blanco, P., Taieb, A., et al. (2017) · British Journal of Dermatology · doi:10.1111/bjd.15550 · Cited by 104
Harnessing dendritic cells in inflammatory skin diseases
Chu, C.-C., Meglio, P. D., & Nestle, F. O. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.01.006 · Cited by 130
Self-citationExpression and Function of Host Defense Peptides at Inflammation Sites
Prasad, S. V., Fiedoruk, K., Daniluk, T., Piktel, E., & Bucki, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010104 · Cited by 114
“In fact, in the skin, this mechanism has been identified as an important initiator of psoriasis development, where LL-37 and defensins are able to condense self-DNA into particles, which are internalized by pDCs, inducing robust IFN-α response via activation of the TLR-9 signaling pathway [119,120].”
Background
Metadata
- Authors
- Lande, R., Gregorio, J., Facchinetti, V., Chatterjee, B., Wang, Y.-H., Homey, B., Cao, W., Wang, Y.-H., Su, B., Nestle, F. O., Zal, T., Mellman, I., Schröder, J.-M., Liu, Y.-J., & Gilliet, M.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Genentech (US)
- Heinrich Heine University Düsseldorf (DE)
- King's College London (GB)
- Christian-Albrechts-Universität zu Kiel (DE)
- Corresponding author
- Gilliet, Michel
- ORCID
- Venue
- Nature
- Published
- 2007-09-16
- Volume
- 449
- Issue
- 7162
- Pages
- 564-569
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2084951281
- Cited by
- 1,910
- References
- 43
- Citations by year
- 2026: 54 · 2025: 61 · 2024: 87 · 2023: 81 · 2022: 94 · 2021: 93 · 2020: 89 · 2019: 97 · 2018: 92 · 2017: 118 · 2016: 105 · 2015: 81 · 2014: 113 · 2013: 120 · 2012: 181
- FWCI
- 38.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI074809)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- plasmacytoid dendritic cells, LL-37, antimicrobial peptides, self-DNA, TLR9, type I interferon, psoriasis, autoimmunity, innate immune tolerance, vaccine adjuvants, skin inflammation
- MeSH terms
- Autoantigens, Autoimmune Diseases, Dendritic Cells, DNA, Endocytosis, Humans, Psoriasis, Endosomes, Autoimmunity, Antimicrobial Cationic Peptides, Toll-Like Receptor 9, Cathelicidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.